Search

Hepatitis Test Solution Market Size to Reach USD 4.35 Billion by 2032 | Growth & Forecasts Global hepatitis test solution/diagnosis market is undergoing steady expansion as healthcare systems worldwide intensify efforts toward early detection, disease control, and viral hepatitis elimination. Valued at USD 2,952 million in 2024, the market is projected to reach USD 4,353 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. This growth is driven by rising disease prevalence, expanding screening programs, and continuous innovation in diagnostic technologies across both developed and emerging healthcare systems. Access the market report https://www.24lifesciences.com/hepatitis-test-solutiondiagnosis-market-9366

Rebound Tonometer Market Size to Reach USD 125 Million by 2031 | Growth Insights & Forecasts Global rebound tonometer market is undergoing steady expansion as ophthalmic care systems worldwide prioritize early detection and long-term management of glaucoma and ocular hypertension. Valued at USD 80.4 million in 2024, the market is projected to grow from USD 85.6 million in 2025 to USD 125 million by 2031, registering a CAGR of 6.6% during the forecast period. This growth reflects rising awareness of preventive eye care, increasing adoption of portable diagnostic technologies, and the growing burden of age-related eye disorders across both developed and emerging economies. Access the full briefing https://www.24lifesciences.com/rebound-tonometer-market-8503

What Is the Future of the Prostate Cancer Diagnostics Market? Growth Forecasts & Insights Global prostate cancer diagnostics market is entering a phase of accelerated expansion, driven by rising cancer prevalence, improved screening awareness, and rapid advances in diagnostic technologies. Valued at USD 14.24 billion in 2024, the market is projected to grow from USD 15.43 billion in 2025 to USD 24.78 billion by 2031, registering a strong CAGR of 8.4% during the forecast period. This growth reflects a global shift toward early detection, risk-adapted screening, and precision diagnostics that support better clinical decision-making and patient outcomes. Read the full market study https://www.24lifesciences.com/prostate-cancer-diagnostics-market-6949

The global Lyme disease testing market is entering a powerful growth phase, propelled by increasing incidence of tick-borne infections, heightened public health awareness, and rapid innovation in diagnostic technologies. Increasing investments in infectious disease screening, early detection initiatives, and healthcare infrastructure modernization are expected to fuel the market through 2035. https://www.factmr.com/report/lyme-disease-testing-market